Note: This episode was recorded as part of the Bio Eats World podcast, now known as Raising Health.
Dan Nomura, PhD, is a distinguished professor at UC Berkeley and an Investigator at the Innovative Genomics Institute, specializing in Chemical Biology and Molecular Therapeutics. He serves as the Director of the Novartis-Berkeley Translational Chemical Biology Institute and founded Frontier Medicines and Vicinitas Therapeutics. He’s also a16z Bio + Health’s newest advisory partner.
In this episode, Dan joins general partner Jorge Conde and investment partner Becky Pferdehirt to discuss how he got started working in chemical biology and chemoproteomics and his experience founding companies, along with leading lab and pharma collaborations.
Jorge Conde is a general partner on the Bio + Health team at Andreessen Horowitz, focused on therapeutics, diagnostics, life sciences tools, and software.
Dan Nomura Dan Nomura is an advisory partner on the a16z Bio + Health team.
Becky Pferdehirt is an investing partner on the Bio + Health team, focusing on early stage companies building technology platforms for therapeutic discovery and development.
Kris Tatiossian is the content lead, life sciences, on the Bio + Health team.
Olivia Webb is the editorial lead, healthcare, on the Bio + Health team.
Biology and the state of healthcare are undergoing radical shifts. Raising Health delves into dialogues with scientists, technologists, founders, builders, leaders, and visionaries as they explore how AI, engineering, and technology elevate health to new heights and create a system of enduring health for all.